Maysaa Chasib Al Mohammedawi has completed her PhD from Al Nahrain University and Postdoctoral studies from Deakin University School of Medicine. Before joining for Postdoctoral studies in Deakin University in 2006, she was an Assistance Professor in the Al-Nahrain University and one of academic staff members of Biotechnology Department and Group Leader of Medical Biotechnology research. Currently she has relocated her works as one of SRF-IIE (US) fellowship into Deakin University with Nanomedicine-Immunology and Molecular Biomedical Research group as Academic Visitor (researcher) and her major field of interest are nanobiotechnology and nanomedicine based drug delivery systems for therapy/diagnosis, biotechnology and molecular biology Maysaa Chasib Al Mohammedawi has completed her PhD from Al Nahrain University and Postdoctoral studies from Deakin University School of Medicine. Before joining for Postdoctoral studies in Deakin University in 2006, she was an Assistance Professor in the Al-Nahrain University and one of academic staff members of Biotechnology Department and Group Leader of Medical Biotechnology research. Currently she has relocated her works as one of SRF-IIE (US) fellowship into Deakin University with Nanomedicine-Immunology and Molecular Biomedical Research group as Academic Visitor (researcher) and her major field of interest are nanobiotechnology and nanomedicine based drug delivery systems for therapy/diagnosis, biotechnology and molecular biology

BACTERIOLOGY,VIROLOGY